WordPress.com Annual Report for 2013
The Louvre Museum has 8.5 million visitors per year. This blog was viewed about 220,000 times in 2013. If it were an exhibit at the Louvre Museum, it would take about 9 days for that many people to see it.
In 2013, there were 958 new posts, growing the total archive of this blog to 1,505 posts. There were 982 pictures uploaded, taking up a total of 253 MB. That’s about 3 pictures per day.
The busiest day of the year was September 19th with 2,501 views. The most popular post that day was Is the Warburg Effect the Cause or the Effect of Cancer: A 21st Century View?.
SOURCE
http://pharmaceuticalintelligence.com/2013/annual-report/
UPDATES on 1/4/2014
On 1/4/2014
We celebrate 1,544 articles, 5,683 tags, 303,847 views, first article 4/30/2012 – Open Access Online Scientific Journal
UPDATED on 11/10/2013
On April 15, 2013
We celebrate 800 articles, 4040 tags, 158,147 views, first article 4/30/2012 – Open Access Online Scientific Journal
On November 10, 2013
We celebrate 1,338 articles, 5,316 tags, 275,104 views, first article 4/30/2012 – Open Access Online Scientific Journal
Encouragement by the Founder: Aviva Lev-Ari, PhD, RN
Updated CURRENT NEEDS on 1/1/2014:
We are SEEKING resources to satisfy our needs at present time:
1. Efforts to find a buyer for our Scientific Journal for 12/2014
http://pharmaceuticalintelligence.com
2. Efforts to find a Publisher for a hardcopy version of a Three Volume Series onCardiovascular Diseases
3. Find few additional Authors for the Journal
4. Find Editors for Cardiovascular Diseases e-Books
5. Find one Editor for Infectious Diseases
6. Find one Editor for immunology
7. Find few Patent Holders in BioMed, for our Business Partner in Shanghai to be connected to Private Equity investors
8. Find Angel Investors for Venture #5
Business Portfolios
VENTURE #1:
e-Publishing: Medicine, HealthCare, Life Sciences, BioMed, Pharmaceutical
- Open Access Online Scientific Journal
http://pharmaceuticalintelligence.com
Site statistics http://pharmaceuticalintelligence.com/wp-admin/index.php?page=stats
- Scoop.it!.com
- http://www.scoop.it/t/cardiotoxicity
- http://www.scoop.it/t/cardiovascular-and-vascular-imaging
- http://www.scoop.it/t/cardiovascular-disease-pharmaco-therapy
1. BioMedical e-Books Series:
http://pharmaceuticalintelligence.com/biomed-e-books/
2. on Amazon’s Kindle e-Books List since 6/2013
3. Plans for Volume 1,2,3 – Hardcover
- Cardiovascular Diseases: Causes, Risks and Management – Volume 1,2,3 – Hardcover
VENTURE #3:
International Scientific Delegations
http://pharmaceuticalintelligence.com/scientific-delegation/
- Shanghai, May 2014
- Barcelona, Spain, November 2014
- Amsterdam, May 2015
- Geneva, November 2015
VENTURE #4:
Joint Ventures
http://pharmaceuticalintelligence.com/joint-ventures/
- Leaders in Pharmaceutical Business Intelligence AND NEW MEDICINE, INC. [ongoing]
- Leaders in Pharmaceutical Business Intelligence AND Bio-Tree Systems [pending Bio-Tree finding funding]
- Leaders in Pharmaceutical Business Intelligence AND Lou Pharma [pending finding Licensees for drugs manufactured in Spain]
- Leaders in Pharmaceutical Business Intelligence AND AlphaSzenszor Inc.
- Leaders in Pharmaceutical Business Intelligence AND ValveCure, LLC
VENTURE #5:
Invented HERE!
1. Development of a NEW Nitric Oxide monitor to Alpha Szenszor Inc. sensor portfolio. A concept for a low cost POC e-nose, capable of real time ppb detection of Cancer
The Cancer Team at Leaders in Pharmaceutical Business Intelligence under the leadership of Dr. Williams
2. Development of a NEW Nitric Oxide monitor to Alpha Szenszor Inc. sensor portfolio. A concept for Inhaled Nitric Oxide for the Adult HomeCare Market –
IP by Dr. Pearlman and Dr. A. Lev-Ari
a. iknow iNO is i-kNOw – Inhaled Nitric Oxide for the HomeCare Market
b. electronic Book on Nitric Oxide by Nitric Oxide Team @ Leaders in Pharmaceutical Business Intelligence (LPBI)
Perspectives on Nitric Oxide in Disease Mechanisms
http://www.amazon.com/dp/B00DINFFYC
c. The rationale and use of inhaled NO in Pulmonary Artery Hypertension and Right Sided Heart Failure
Larry H. Bernstein 8/20/2012
d. Inhaled Nitric Oxide in Adults: Clinical Trials and Meta Analysis Studies – Recent Findings
Aviva Lev-Ari, PhD, RN, 6/2/2013
3. Cancer Genomics for NEW product development in diagnosis and treatment of Cancer Patients using sensory technology with applications for Radiation Therapy – The Cancer Team at Leaders in Pharmaceutical Business Intelligence under leadership of Dr. Sidney Kadish.
4. Developing Mitral Valve Disease: MRI Methods and Devices for Percutaneous Mitral Valve Replacement and Mitral Valve Repair
Augmentation of Patented Technology using RF – Dr. Pearlman’s IP Non-Hardware Mitral Annuloplasty – Dr. Justin D. Pearlman
5. Novel Technology using MRI for Vascular Lesions, Tumors, Hyperactive Glands and non-Surgical Cosmetic Reconstruction – Dr. Pearlman’s IP
http://pharmaceuticalintelligence.com/biomed-e-books/series-a-e-books-on-cardiovascular-diseases/httppharmaceuticalintelligence-combiomed-e-bookscardiovascular-diseases-causes-risks-and-management/cvd-business-affairs/mitral-valve-disease-mri-methods-and-devices/
VENTURE # 6:
PRESS Coverage of Conferences
I actually consider this amazing blog , âSAME SCIENTIFIC IMPACT: Scientific Publishing –
Open Journals vs. Subscription-based « Pharmaceutical Intelligenceâ, very compelling plus the blog post ended up being a good read.
Many thanks,Annette
I actually consider this amazing blog , âSAME SCIENTIFIC IMPACT: Scientific Publishing –
Open Journals vs. Subscription-based « Pharmaceutical Intelligenceâ, very compelling plus the blog post ended up being a good read.
Many thanks,Annette
I actually consider this amazing blog , âSAME SCIENTIFIC IMPACT: Scientific Publishing –
Open Journals vs. Subscription-based « Pharmaceutical Intelligenceâ, very compelling plus the blog post ended up being a good read.
Many thanks,Annette